Project Gutenberg
Resumption of Palestine Conference, January 1947. Note No. 385 to Saudi Arabian Ministry of Foreign Affairs. 1947. ...
1947 - Gale Group | ArchivesUnbound Arabi Israeli
Farah Perveen Mughal, Ann Christina Bergmann, Ha Uyen Buu Huynh, Sarah Hyllekvist Jørgensen, Inaam Mansha, Meliha Kesmez, Patrick M. Schürch, Alexandre Theocharides, Per Brinch Hansen, T Friis, Morten Orebo Holmström, Evaldas Čiplys, Rimantas Slibinskas, Peter Højrup, Gunnar Houen, Nicole Hartwig Trier,
... reacted to two epitopes: CREACLQGWTE for SSI-HYB 385-01, 385-02, 385-03, 385-04, 385-07, 385-08, and 385-09 and CLQGWT for SSI-HYB 385-06. For the majority of antibodies, the residues ... and Glu11 were essential for reactivity. SSI-HYB 385-06, with the highest affinity, recognised recombinant CRTfs ... when examined in Western immunoblotting. Moreover, SSI-HYB 385-06 occasionally reacted to CRTfs from MPN patients ...
Tópico(s): Chronic Myeloid Leukemia Treatments
2022 - Multidisciplinary Digital Publishing Institute | International Journal of Molecular Sciences
Project Gutenberg
1889, Diplomatic: Volume 385:1 Letter. To Mr. Trench.
0000 - Gale Group | NCCO AsiaWest
Holly Kramer, Bernard G. Jaar, Michael Choi, Paul M. Palevsky, Joseph A. Vassalotti, Michael V. Rocco,
... GFR without race.N Engl J Med. 2021; 385: 1737-1749https://doi.org/10.1056/NEJMoa2102953Crossref PubMed ... GFR without race.N Engl J Med. 2021; 385: 1737-1749https://doi.org/10.1056/NEJMoa2102953Crossref PubMed ... GFR without race.N Engl J Med. 2021; 385: 1737-1749https://doi.org/10.1056/NEJMoa2102953Crossref PubMed ... GFR without race.N Engl J Med. 2021; 385: 1737-1749https://doi.org/10.1056/NEJMoa2102953Crossref PubMed ... function in CKD.N Engl J Med. 2021; 385: 1750-1760https://doi.org/10.1056/NEJMoa2103753Crossref PubMed ...
Tópico(s): Dialysis and Renal Disease Management
2022 - Elsevier BV | American Journal of Kidney Diseases
1889, Diplomatic: Volume 385:1 Letter. To Mr. Trench.
0000 - Gale Group | NCCO AsiaWest
Mitchel Okumu, Minal Naran Patel, Foram Rajnkant Bhogayata, Irene Awuor Olweny, Francis Okumu Ochola, Joshua Orungo Onono,
... inferential analysis was set at 5%. There were 385 cases of poisoning: 57.9% (223/385) were male, 31.9% (123/385) were 13⁻24 years of age, and 83.9% (323/385) of exposures were in Kisumu County. The peak ... 6:00⁻00:00, and 23.6% (91/385) presented 1⁻4 h after exposure. About 62.9% (242/385) of the cases were due to accidental poisoning. ... and organophosphates (OPPs) contributed to 33.0% (127/385) and 22.1% (85/385) of all cases, respectively. About 62.1% (239/385) of exposures were oral, and 63.9% (246/385) of all cases occurred in the rainy season. ...
Tópico(s): Malaria Research and Control
2018 - Multidisciplinary Digital Publishing Institute | Tropical Medicine and Infectious Disease
1889, Diplomatic: Volume 385:1
0000 - Gale Group | NCCO AsiaWest
Fred Saad, James L. Bailen, Christopher Pieczonka, Daniel R. Saltzstein, Paul Sieber, David B. MacLean, Hongliang Shi, Hélène M. Faessel, Neal D. Shore,
... and thus may avoid clinical flare symptomatology. TAK-385 is an investigational, oral, non-peptide GnRH antagonist ... randomized, open label, parallel group study of TAK-385 in pts with advanced prostate cancer (NCT02083185). Methods: ... deprivation therapy, were randomized to receive oral TAK-385, 80 or 120 mg, once daily (QD) or ... primary endpoint was effective castration rate of TAK-385 (T < 50 ng/dL) from wk 5–24. ... data cut-off, 75 pts had received TAK-385 (39 at 80 mg, 36 at 120 mg ... LEU. Median age was 73 yrs with TAK-385 and 68.5 yrs with LEU; median treatment ...
Tópico(s): Estrogen and related hormone effects
2016 - Lippincott Williams & Wilkins | Journal of Clinical Oncology
1889, Diplomatic: Volume 385:1
0000 - Gale Group | NCCO AsiaWest
Li Liu, Robert E. Black, Simon Cousens, Colin Mathers, Joy E. Lawn, Daniel R Hogan,
... 2015 priorities: an updated systematic analysis.Lancet. 2015; 385: 430-440Summary Full Text Full Text PDF PubMed ... Global Burden of Disease Study 2013.Lancet. 2015; 385: 117-171Summary Full Text Full Text PDF PubMed ... Global Burden of Disease Study 2013.Lancet. 2015; 385: 117-171Summary Full Text Full Text PDF PubMed ... Global Burden of Disease Study 2013.Lancet. 2015; 385: 117-171Summary Full Text Full Text PDF PubMed ... Global Burden of Disease Study 2013.Lancet. 2015; 385: 117-171Summary Full Text Full Text PDF PubMed ...
Tópico(s): Neonatal Respiratory Health Research
2015 - Elsevier BV | The Lancet
1889, Diplomatic: Volume 385:1
0000 - Gale Group | NCCO AsiaWest
David B. MacLean, Hongliang Shi, Hélène M. Faessel, Fred Saad,
TAK-385 is a highly selective, oral, nonpeptide GnRH antagonist being investigated as a possible prostate cancer treatment. The ... evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-385 on LH and testosterone. This was a three- ... UK volunteers. Part 1, single doses of TAK-385 (0 [placebo], 80, 120, 180, or 360 mg). Part 2, 14-day TAK-385 (0, 20, 40, 80, or 180 mg) daily. Part 3, 28-day TAK-385 (40 [with loading dose], 60, 80, or 160 ... Main outcome measures included plasma concentrations of TAK-385, LH, and testosterone. Oral TAK-385 was readily ...
Tópico(s): Estrogen and related hormone effects
2015 - Oxford University Press | The Journal of Clinical Endocrinology & Metabolism
1889, Diplomatic: Volume 385:1 Letter. To Mr. Trench.
0000 - Gale Group | NCCO AsiaWest
Produção Nacional
Revisado por pares
Ruffo Freitas‐Júnior, Leonardo Ribeiro Soares, Carlos H. Barrios,
... registries in 67 countries (CONCORD-2).Lancet. 2015; 385: 977-1010Summary Full Text Full Text PDF PubMed ... registries in 67 countries (CONCORD-2).Lancet. 2015; 385: 977-1010Summary Full Text Full Text PDF PubMed ... registries in 67 countries (CONCORD-2).Lancet. 2015; 385: 977-1010Summary Full Text Full Text PDF PubMed ... registries in 67 countries (CONCORD-2).Lancet. 2015; 385: 977-1010Summary Full Text Full Text PDF PubMed ... registries in 67 countries (CONCORD-2).Lancet. 2015; 385: 977-1010Summary Full Text Full Text PDF PubMed ...
Tópico(s): Cancer Risks and Factors
2015 - Elsevier BV | The Lancet
1889, Diplomatic: Volume 385:1
0000 - Gale Group | NCCO AsiaWest
Peter Lloyd‐Sherlock, Shah Ebrahim, Martin McKee, Martin Prince,
... UN Sustainable Development Goal for health.Lancet. 2015; 385: 239-252Summary Full Text Full Text PDF PubMed ... UN Sustainable Development Goal for health.Lancet. 2015; 385: 239-252Summary Full Text Full Text PDF PubMed ... UN Sustainable Development Goal for health.Lancet. 2015; 385: 239-252Summary Full Text Full Text PDF PubMed ... UN Sustainable Development Goal for health.Lancet. 2015; 385: 239-252Summary Full Text Full Text PDF PubMed ... implications for health policy and practice.Lancet. 2015; 385: 549-562Summary Full Text Full Text PDF PubMed ...
Tópico(s): Health disparities and outcomes
2015 - Elsevier BV | The Lancet
Alexander Street
1889, Diplomatic: Volume 385:1 Letter. To Mr. Fraser.
0000 - Gale Group | NCCO AsiaWest
Bradley G. Leshnower, Ravi Veeraswamy, Yazan Duwayri, Edward P. Chen,
... Aortic Dissection.J Thorac Cardiovasc Surg. 2013; 145: 385-390Abstract Full Text Full Text PDF PubMed Scopus ( ... Aortic Dissection.J Thorac Cardiovasc Surg. 2013; 145: 385-390Abstract Full Text Full Text PDF PubMed Scopus ( ... Aortic Dissection.J Thorac Cardiovasc Surg. 2013; 145: 385-390Abstract Full Text Full Text PDF PubMed Scopus ( ... Aortic Dissection.J Thorac Cardiovasc Surg. 2013; 145: 385-390Abstract Full Text Full Text PDF PubMed Scopus ( ... Aortic Dissection.J Thorac Cardiovasc Surg. 2013; 145: 385-390Abstract Full Text Full Text PDF PubMed Scopus ( ...
Tópico(s): Cardiac Valve Diseases and Treatments
2014 - Elsevier BV | The Annals of Thoracic Surgery
Alexander Street
1889, Diplomatic: Volume 385:1 Letter. To Mr. Trench.
0000 - Gale Group | NCCO AsiaWest
Pengbo Liu, Xiaoqin Wang, Joong-Chul Lee, Peter Teunis, Senke Hu, Helen Tang Paradise, Christine L. Moe,
... 22) of children with homozygous secretor genotype (Se 385 Se 385), heterozygous secretor genotype (Se 385 se 385) and homozygous weak secretor genotype (se 385 se 385), respectively. Children with secretor genotypes Se 385 Se 385 and Se 385 se 385 were significantly (P < 0.05) more susceptible to ...
Tópico(s): Animal Virus Infections Studies
2014 - Lippincott Williams & Wilkins | The Pediatric Infectious Disease Journal